Scientists found mechanism of acquired resistance to EGFR tyrosine kinase inhibitors
Published: 2012-11-15 06:56:00
Updated: 2012-11-15 06:56:00
A group of scientists at Yonsei University have found a mechanism of acquired resistance to EGFR (epidermal growth factor receptor) tyrosine kinase inhibitors (TKI) in non–small cell lung cancer (NSCLC)., a discovery which accelerate development of a novel EGFR related medicine.
The Korea Heal...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
